 |
|
|
|
 |
|
Pathogenesis of Pandemic Influenza A (H1N1) and Triple-Reassortant Swine Influenza A (H1) Viruses in Mice
Belser JA, Wadford DA, Pappas C, Gustin KM, Maines TR, Pearce MB, Zeng H, Swayne DE, Pantin-Jackwood M, Katz JM, Tumpey TM.
J Virol. 2010 May;84(9):4194-203. Epub 2010 Feb 24. (Abstract, Fulltext, PDF)
|
|
Mutations in the NS1 C-terminal tail do not enhance replication or virulence of the 2009 pandemic H1N1 influenza A virus.
Hale BG, Steel J, Manicassamy B, Medina RA, Ye J, Hickman D, Lowen AC, Perez DR, Garcia-Sastre A.
J Gen Virol. 2010 Mar 17. [Epub ahead of print] (Abstract)
|
|
Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.
Guy B, Guirakhoo F, Barban V, Higgs S, Monath TP, Lang J.
vaccine 2010 Jan 8;28(3):632-49. Epub 2009 Oct 4. (Abstract)
|
|
A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults.
Morrison D, Legg TJ, Billings CW, Forrat R, Yoksan S, Lang J.
J Infect Dis. 2010 Feb 1;201(3):370-7. (Abstract)
|
|
AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice.
Caillet C, Piras F, Bernard MC, de Montfort A, Boudet F, Vogel FR, Hoffenbach A, Moste C, Kusters I.
Vaccine. 2010 Apr 19;28(18):3076-9. Epub 2010 Mar 1. (Abstract)
|
|
Reassortment between avian H5N1 and human H3N2 influenza viruses creates hybrid viruses with substantial virulence.
Li C, Hatta M, Nidom CA, Muramoto Y, Watanabe S, Neumann G, Kawaoka Y.
Proc Natl Acad Sci U S A. 2010 Mar 9;107(10):4687-92. Epub 2010 Feb 22. (Abstract, Fulltext, PDF)
|
|
Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys.
David E. Clements, Beth-Ann G. Coller, Michael M. Lieberman, Steven Ogata, Gordon Wang, Kent E. Harada, J. Robert Putnak, John M. Ivy, Michael McDonell, Gary S. Bignami, Iain D. Peters, Julia Leung, Carolyn Weeks-Levy, Eileen T. Nakano and Tom Humphreys
Vaccine. 2010 March; 28(15): 2705-2715. (Abstract)
|
|
Prediction of avian influenza A binding preference to human receptor using conformational analysis of receptor bound to hemagglutinin.
Nipa Jongkon, Wanwimon Mokmak, Daungmanee Chuakheaw, Philip J Shaw, Sissades Tongsima, and Chak Sangma
BMC Genomics. 2009; 10(Suppl 3): S24. (Abstract, Fulltext, PDF)
|
|
Priming Immunization with DNA Augments Immunogenicity of Recombinant Adenoviral Vectors for Both HIV-1 Specific Antibody and T-Cell Responses.
Richard A. Koup, Mario Roederer, Laurie Lamoreaux, Jennifer Fischer, Laura Novik, Martha C. Nason, Brenda D. Larkin, Mary E. Enama, Julie E. Ledgerwood, Robert T. Bailer, John R. Mascola, Gary J. Nabel, Barney S. Graham, and the VRC 009 and VRC 010 Study Teams
PLoS One. 2010; 5(2): e9015. (Abstract, Fulltext, PDF)
|
|
Identification of Amino Acids in HA and PB2 Critical for the Transmission of H5N1 Avian Influenza Viruses in a Mammalian Host
Yuwei Gao, Ying Zhang, Kyoko Shinya, Guohua Deng, Yongping Jiang, Zejun Li, Yuntao Guan, Guobin Tian, Yanbing Li, Jianzhong Shi, Liling Liu, Xianying Zeng, Zhigao Bu, Xianzhu Xia, Yoshihiro Kawaoka, and Hualan Chen
PLoS Pathog. 2009 December; 5(12): e1000709. (Abstract, Fulltext, PDF)
|
|
1918 and 2009 H1N1 influenza are not pathogenic in birds.
Babiuk S, Albrecht R, Berhane Y, Marszal P, Richt JA, García-Sastre A, Pasick J, Weingartl H.
J Gen Virol. 2010 Feb;91(Pt 2):339-42. Epub 2009 Nov 4. (Abstract, Fulltext, PDF)
|
|
Enhancement of Reverse Genetics-derived Swine-Origin H1N1 Influenza Virus Seed Vaccine Growth by Inclusion of Indigenous Polymerase PB1 Protein
Wanitchang A, Kramyu J, Jongkaewwattana A.
Virus Res. 2010 Jan;147(1):145-8. Epub 2009 Oct 30. (Abstract)
|
| |
|
|
| |
|
|
| |
|
